By Dan Primack
September 3, 2013

Microsoft Corp. (Nasdaq: MSFT) has agreed to acquire Nokia’s devices and services business, license Nokia’s patents and license and use Nokia’s mapping services. The entire deal is valued at nearly $7.2 billion, and is expected to close in Q1 2014. www.microsoft.com

Amdocs (NYSE: DOX) has agreed to acquire Actix, a UK–based provider of provider of mobile network optimization software, from Summit Partners. The deal is valued at $120 million in cash. www.amdocs.com

Cumulus Media (Nasdaq: CMLS) has agreed to acquire New York-based radio programming syndicator Dial Global. The deal is valued at approximately $260 million. www.dialglobal.com

Dogan Holding of Turkey has made a $742 million non-binding offer for a 53% stake in Turkish pay-television company Digiturk. This is 40% higher than an earlier bid for the stake from Turk Telecom.www.doganholding.com.tr

Vodafone (LSE: VOD) announced that it has agreed to sell its 45% stake in Verizon Wireless to joint venture partner Verizon Communications (NYSE: VZ), in a deal valued at approximately $130 billion. www.vodafone.com

Bright Food Group of China said that it’s in talks about a possible acquisition of Israeli food companyTnuva, in which Apax Partners folds a 56% stake. A Chinese news report suggests that the total deal could be valued at around $1.6 billion. www.tnuva.co.il

Jarden Corp. (NYSE: JAH) has agreed to acquire Yankee Candle from Madison Dearborn Partners for approximately $1.75 billion in cash. Madison Dearborn had acquired the South Deerfield, Mass.-based company back in 2006 for $1.4 billion.  www.yankeecandle.com

Meda AB (Oslo: MEDA) has agreed to acquire Acton Pharmaceuticals Inc., a Marlborough, Mass.-based respiratory medicine company, for up to $200 million in cash. The deal includes a $135 million up-front payment and up to $65 million in milestone payments. Acton shareholders include Sequoia Capitalwww.actonpharmcaeuticals.com

Rakuten of Japan has acquired Viki, a community-powered site that allows users to watch TV and movies in their own language. No financial terms were disclosed, although AllThingsD puts the price-tag at around $200 million. Viki had raised around $24 million in VC funding from Greylock Partners, Andreessen Horowitz, Charles River Ventures, SK Planet and Neoteny Labs. www.viki.com

The Riverside Company has sold AIA Corp., a Neenah, Wis.-based provider of promotional products and corporate apparel, to an undisclosed buyout. No financial terms were reported.www.riversidecompany.com

AMC Entertainment has filed for a $400 million IPO. It plans to trade on the NYSE under ticker symbol AMC. The Leawood, Kansas-based movie theater chain was acquired last year for $2.6 billion (including debt) by Chinese movie theater operator Wanda Group, from an investor group that included JPMorgan Partners, Appollo Management, Bain Capital, The Carlyle Group and Spectrum Equity Investors. AMC had been in registration for a $450 million IPO at the time, but pulled the offering in light of the acquisition agreement. www.amcentertainment.com

Evoke Pharma Inc.
, a San Diego-based drug developer focused on gastrointestinal disorders, has set its IPO terms to 2.1 million shares being offered at between $12 and $14 per share. It would have an initial market cap of around $75 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol EVOK, with Aegis Capital Corp. serving as lead underwriter. Shareholders include Domain Associates (30.9%), Latterell Venture Partners (30.9%) and Windamere Venture Partners. www.evokepharma.com

Fate Therapeutics
, a San Diego-based stem cell biotech company focused on cellfate control, has set its IPO terms to 4 million shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $189.5 million, were it to price in the middle of its range. It will trade on the Nasdaq under ticker symbol FATE, with Cowen & Co. and BMO Capital Markets serving as lead underwriters. The company reports a $9.1 million net loss on $762,000 in revenue for the first half of 2013. The company has raised over $42 million in VC funding from ARCH Venture Partners (16.8% pre-IPO stake), Polaris Partners (16.8%), Venrock (16.8%) and OVP Venture Partners (15.4%).www.fatetherapeutics.com

Volaris Aviation, a Mexican airline carrier, has set its IPO terms to 28.8 million American depository shares being offered at between $12 and $14 per share. It plans to trade on both the NYSE and Mexican Stock Exchange, with Deutsche Bank, Morgan Stanley and UBS serving as lead underwriters. www.volaris.mx/es

Sign up for Dan’s daily email newsletter on deals and deal-makers: GetTermSheet.com

You May Like

EDIT POST